Get the Stockscreener App
2.01
0.50%
-0.01
Seer Inc stock is traded at $2.01, with a volume of 1,696.
It is down -0.50% in the last 24 hours and down -2.90% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$2.02
Open:
$2
24h Volume:
1,696
Relative Volume:
0.01
Market Cap:
$129.46M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.5462
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-9.87%
1M Performance:
-2.90%
6M Performance:
-14.83%
1Y Performance:
+16.86%
1-Day Range:
$2.00
$2.01
1-Week Range:
$2.00
$2.28
52-Week Range:
$1.56
$2.625
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.01 | 129.46M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.87 | 114.57B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
516.94 | 55.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
305.70 | 39.64B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.31 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.92 | 28.55B | 3.81B | -644.79M | -669.77M | -6.24 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Insider Sell Alert: Dipchand Nishar Sells 30,253 Shares of Seer Inc (SEER) - GuruFocus
Seer director Nishar Dipchand sells shares worth $62,935 - Investing.com
Seer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young Adults - MSN
Seer, Inc. (NASDAQ:SEER) Shares Bought by Bank of America Corp DE - Defense World
HomeXpress Mortgage Corp. Announces Definitive Agreement to be Acquired by Chimera Investment Corporation - Business Wire
Squarepoint Ops LLC Trims Stake in Seer, Inc. (NASDAQ:SEER) - Defense World
Kalkine : Top NASDAQ Companies by Market Cap Featuring Seer Inc - Kalkine Media
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now? - sharewise
Strategic Environmental & Energy Resources, Inc. SEC 10-K Report - TradingView
Two Sigma Investments LP Sells 12,930 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Millennium Management LLC Has $1.42 Million Stock Holdings in Seer, Inc. (NASDAQ:SEER) - Defense World
Korea University partners with US-based Seer to develop AI-driven diagnostics for cancers in young adults - BioSpectrum Asia
Seer : Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers (Form 8-K) - marketscreener.com
Seer (SEER) Launches Groundbreaking Cancer Biomarker Study | SEE - GuruFocus
Northern Trust Corp Buys 50,992 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Seer's Proteograph Platform Enables Unprecedented 20,000-Sample - GuruFocus
Seer, Inc. and Korea University Launch First Large-Scale Study to Identify Early-Onset Cancer Biomarkers Using Proteograph ONE Assay - Nasdaq
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea ... - Enidnews.com
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults - GlobeNewswire
Groundbreaking 20,000-Sample Study Targets Hidden Cancers in Young Adults Using AI-Powered Blood Test - Stock Titan
Seer Inc. unveils advanced proteomics suite By Investing.com - Investing.com South Africa
Seer (SEER) Unveils Advanced Proteograph Product Suite | SEER St - GuruFocus
Seer Inc. unveils advanced proteomics suite - Investing.com Australia
Seer Redefining Deep Unbiased Proteomics with Launch of New Prot - GuruFocus
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency | SEER Stock News - GuruFocus
Seer Redefining Deep Unbiased Proteomics with Launch of New - GlobeNewswire
New Proteograph ONE Platform Revolutionizes Protein Analysis: 1000+ Samples Per Week at 60% Lower Cost - Stock Titan
Company News for May 27, 2025 - The Globe and Mail
Have Seer Insiders Been Selling Stock? - simplywall.st
Seer Inc. Hold Rating: Balancing Impressive Revenue Growth with Market Uncertainties - TipRanks
Top Executives Unload Seer Stock in Major Transactions - TipRanks
D. E. Shaw & Co. Inc. Acquires 103,630 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Cubist Systematic Strategies LLC Sells 46,541 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Dimensional Fund Advisors LP Buys 5,000 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Seer reiterates $17M–$18M 2025 revenue guidance amid strong Q1 instrument demand and large-scale study momentum - MSN
US$3.00: That's What Analysts Think Seer, Inc. (NASDAQ:SEER) Is Worth After Its Latest Results - simplywall.st
Seer, Inc. Reports Strong Q1 2025 Earnings - TipRanks
Barclays PLC Decreases Stake in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates - MSN
Quarterhill Announces Q1 2025 Financial Results - The Globe and Mail
Seer, Inc. (NASDAQ:SEER) Q1 2025 Earnings Call Transcript - Insider Monkey
Seer (SEER) Anticipates Revenue Growth in 2025 | SEER Stock News - GuruFocus
Seer Inc (SEER) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance
Seer, Inc. Reports Strong Q1 2025 Growth - TipRanks
Seer Q1 2025 Earnings Call Transcript - MarketBeat
Seer (SEER) Surpasses Q1 Revenue Expectations with Strong Perfor - GuruFocus
Earnings call transcript: Seer Q1 2025 sees strong revenue growth, stock jumps - Investing.com Australia
Seer Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Seer Inc (SEER) Q1 2025 Earnings: EPS of -$0.34 Beats Estimate, Revenue Surges to $4.2 Million - GuruFocus
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook - The Manila Times
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):